Tesamorelin

Secretagogue Peptide

Tesamorelin

Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) widely studied for its role in endogenous growth hormone signaling and endocrine pathway modulation.

1
$69.99
Most Popular
Best Value
Pre-order · Ships Jul 21 - Jul 24
Free shipment protection
Secure checkout
We accept: Visa Mastercard American Express
Free shipping on orders over $200
Damage protection on every order
Secure checkout 256-bit SSL
Certificate of Analysis
Tested for Identification, Purity, Mass, Endotoxins, Sterility, and Heavy Metals
LATEST 6× TESTED
99.27%
PURITY
Variant Tesamorelin 10MG
Lot # TESA-2601-A01
Labeled 10mg
Actual 10.49mg
Tested March 14, 2026
Heavy Metals Within Limits
Endotoxins Pass
Sterility No Growth
Compound Information
Pharmaceutical Specifications
Molecular Profile
What Is Tesamorelin?
TypeSynthetic peptide
CAS Number218949-48-5
Molecular FormulaC₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight5,135.77 g/mol
Amino Acids44
PubChem Database
Storage Requirements
Stability Information
Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder)
-20°C  ·  24+ months
Reconstituted
2-8°C  ·  ~7 days
Research
Sources & References
NEW ENGLAND JOURNAL OF MEDICINE
Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV
2008  ·  DOI: 10.1056/NEJMoa072375
Falutz J, Allas S, Blot K, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S
View Source
LANCET HIV (ELSEVIER)
Effects of Tesamorelin on Non-Alcoholic Fatty Liver Disease in HIV: A Randomised, Double-Blind, Multicentre Trial
2019  ·  DOI: 10.1016/S2352-3018(19)30338-8
Stanley TL, Fourman LT, Feldpausch MN, Purdy J, Zheng I, Pan CS, Aepfelbacher J, Buckless C, Tsao A, Kellogg A, Branch K, Lee H, Liu CY, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SK
View Source
JAMA (AMERICAN MEDICAL ASSOCIATION)
Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients with Abdominal Fat Accumulation: A Randomized Clinical Trial
2014  ·  DOI: 10.1001/jama.2014.8334
Stanley TL, Feldpausch MN, Oh J, Branch KL, Lee H, Torriani M, Grinspoon SK
View Source
ARCHIVES OF NEUROLOGY (AMA/JAMA NETWORK)
Effects of Growth Hormone-Releasing Hormone on Cognitive Function in Adults with Mild Cognitive Impairment and Healthy Older Adults: Results of a Controlled Trial
2012  ·  DOI: 10.1001/archneurol.2012.1970
Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV
View Source
JAMA NEUROLOGY (AMA/JAMA NETWORK)
Growth Hormone-Releasing Hormone Effects on Brain γ-Aminobutyric Acid Levels in Mild Cognitive Impairment and Healthy Aging
2013  ·  DOI: 10.1001/jamaneurol.2013.1425
Friedman SD, Baker LD, Borson S, Jensen JE, Barsness SM, Craft S, Merriam GR, Otto RK, Novotny EJ, Vitiello MV
View Source
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ENDOCRINE SOCIETY)
Effects of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat: A Pooled Analysis of Two Phase 3 Trials with Safety Extension Data
2010  ·  DOI: 10.1210/jc.2010-0490
Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S
View Source
JOURNAL OF FRAILTY & AGING (SERDI)
The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV
2019  ·  DOI: 10.14283/jfa.2018.45
Adrian S, Scherzinger A, Sanyal A, Lake JE, Falutz J, Dubé MP, Stanley T, Grinspoon S, Mamputu JC, Marsolais C, Brown TT, Erlandson KM
View Source
OBESITY RESEARCH & CLINICAL PRACTICE (ELSEVIER)
Body Composition, Hepatic Fat, Metabolic, and Safety Outcomes of Tesamorelin, a GHRH Analogue, in HIV-Associated Lipodystrophy: A Meta-Analysis of Randomized Controlled Trials
2026  ·  DOI: 10.1016/j.orcp.2026.01.001
Samy Abdelkader et al.
View Source
PMC/OPEN ACCESS (NIH)
Visceral Fat Reduction with Tesamorelin Is Associated with Improved Liver Enzymes in HIV
2017  ·  DOI: 10.1371/journal.pone.0181229
Fourman LT, Czerwonka N, Feldpausch MN, Weiss J, Branch KL, Lee H, Torriani M, Hadigan CM, Stanley TL, Grinspoon SK
View Source
ANNALS OF PHARMACOTHERAPY (SAGE)
Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy
2012  ·  DOI: 10.1345/aph.1Q629
Spooner LM, Olin JL
View Source
Tesamorelin $69.99

Secretagogue Peptide

Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) widely studied for its role in endogenous growth hormone signaling and endocrine pathway modulation.

Additional information

Quantity:

10MG

You May Also Like